oxybutynin chloride 1 MG/ML Oral Solution

What the CMS Formulary Data Shows for oxybutynin chloride 1 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, oxybutynin chloride 1 MG/ML Oral Solution (RxNorm concept RXCUI 863599, generic name oxybutynin chloride) appears on 317 distinct formulary files spanning 4,992 Medicare Part D plan offerings - 98.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.

Real-world access to oxybutynin chloride 1 MG/ML Oral Solution depends on utilization management as much as tier placement: 0.6% of covering formularies require prior authorization. 0% require step therapy. 48.9% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 881,680 Part D beneficiaries filled oxybutynin chloride 1 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $113,070,736 and an average per-beneficiary annual cost of $128.24. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry oxybutynin chloride 1 MG/ML Oral Solution today.